Bing Tseu
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Multiple Myeloma Research and Treatments, Acute Kidney Injury Research, Trauma, Hemostasis, Coagulopathy, Resuscitation, Cardiac, Anesthesia and Surgical Outcomes
Most-Cited Works
- → FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion(2014)36 cited
- → Impaired humoral and cellular response to primary COVID‐19 vaccination in patients less than 2 years after allogeneic bone marrow transplant(2022)20 cited
- → Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma(2020)13 cited
- → Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation(2019)13 cited
- → Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort(2022)7 cited
- → Daratumumab Monotherapy for Heavily Pre-treated and Refractory Myeloma: Results from a UK Multicentre Real World Cohort(2021)4 cited
- → Myeloma clinical outcomes following the first wave of COVID‐19: results from the Thames Valley Cancer Alliance (UK)(2020)3 cited
- → Beta thalassemia major and Noonan syndrome — Two genetic disorders manifest in the blood film(2020)
- → P1707: FACTORS ASSOCIATED WITH A LYMPHOMA DIAGNOSIS PRIOR TO BIOPSY(2022)